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Abstract Escherichia coli biotin carboxylase was affinity
labeled with adenosine diphosphopyridoxal to identify its ATP
binding site. Lysyl endopeptidase digestion of the modified
protein, followed by high performance liquid chromatography
separation and amino acid sequencing allowed to identify lysine-
238 to be the site of modification. Site-directed mutagenesis of
this residue into alanine, arginine or glutamine resulted in
mutants with much decreased activity. Lysine-238 seems to
interact with the Q-phosphate group of ATP but is not involved in
catalysis.
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1. Introduction
Acetyl-CoA carboxylase (ACC) is the rate-determining en-
zyme in fatty acid synthesis. ACC from Escherichia coli and
other bacteria is composed of the following three subunits :
biotin carboxylase (BC) which mediates the carboxylation of
enzyme-bound biotin, carboxyl transferase (CT) which medi-
ates transfer of the carboxyl group from carboxybiotin to
acetyl-CoA and the biotin-carrying protein [1,2]. On the basis
of the deduced amino acid sequence of E. coli BC, the glycine-
rich region Gly-Gly-Gly-Gly-Arg-Gly at amino acid numbers
163^168 was presumed to be the ATP-binding site of this
enzyme [3]. But according to the recently reported three-di-
mensional structure of E. coli BC, the glycine-rich region is
located in the ‘B domain’, away from the center of the puta-
tive active site cavity [4]. Therefore, precise location of ATP-
binding sites remains to be solved. To identify these sites, we
used an a⁄nity labeling technique. The labeling agent adopted
was adenosine diphosphopyridoxal (AP2-PL), which is ex-
pected and has been proven to modify lysine residue(s) located
at the ATP-binding site of enzymes [5]. The data shown below
reveal that this reagent modi¢ed exclusively Lys-238 located in
the putative active site cavity of BC. Site-directed mutagenesis
of Lys-238 shows that this residue is involved in the binding
of ATP with electrostatic interaction.
2. Materials and methods
2.1. Materials
Taq DNA polymerase, plasmid pTV119N and restriction enzymes
were purchased from Takara Shuzou, Kyoto. Plasmid pTrc99A and
E. coli strain JM109 were obtained from Pharmacia. Plasmid pBlue-
script II SK+ was from Stratagene. Biotin and lysyl endopeptidase
were obtained from Wako, Osaka. Oligonucleotides were synthesized
with an Applied Biosystems DNA synthesizer model 391. AP2-PL was
synthesized as described previously [6]. High performance liquid chro-
matography was run on a Hitachi chromatograph. Reversed phase C4
and C18 columns were purchased from Nacalai Tesque, Kyoto. Flu-
orescence chromatograms were obtained on a Hitachi spectrophotom-
eter F-1050. The £uorescence intensity of a pyridoxamine derivative
prepared by treating a mixture of 100 WM AP2-PL and 1 M tris(hy-
droxymethyl)aminomethane with 1 mM sodium borohydride was tak-
en as the standard for the BC-bound £uorescence derived from AP2-
PL. Amino acid sequence was determined on an Applied Biosystems
sequenator 491A.
2.2. Construction of an expression plasmid for BC
An over-expression plasmid for E. coli BC was prepared by ligating
its gene (1347 bp) with plasmid pTrc99A. The details of this construc-
tion will be reported elsewhere. Brie£y, the entire coding region of E.
coli BC and its downstream region were divided into four segments
(S1^S4 from the 5P terminus). Their sizes were the following: S1, 396
bp; S2, 426 bp; S3, 205 bp; and S4, 337 bp. Each segment was
endowed a restriction enzyme site at both ends by minimal mutation
of bases in such a way that no amino acid substitution is produced
with an exception of the second residue from the amino terminus.
Individual segments were ampli¢ed separately by the polymerase
chain reaction in a 100-Wl solution containing 10 mM Tris-HCl (pH
8.9), 25 mM MgCl2, 80 mM KCl, 0.2 mM each of deoxynucleotides
(dATP, dGTP, dCTP and dTTP), 0.2 WM each of a combination of
appropriate primers, 0.5 ng of pAK-1, E. coli genomic DNA clone
containing the entire BC coding region [3], and 5 units of Taq polym-
erase with a program consisting of 94‡C for 3 min, 50‡C for 2 min
and 72‡C for 3 min in the ¢rst cycle and 94‡C for 1 min, 50‡C for
2 min and 72‡C for 3 min in 2^35 cycles in a thermal cyclic reactor
(Astec, Fukuoka, PC-700). E. coli DNAs thus ampli¢ed were digested
with appropriate restriction enzymes and ligated into plasmid pBlue-
script II SK+ or pTV119N to determine nucleotide sequence [7]. It
was con¢rmed that no undesired mutation had taken place on the
ampli¢ed DNAs. The insert DNAs were recloned into pTrc99A to
complete an expression plasmid for BC, pTBC. Because of the engi-
neering of its sequence, pTBC generated E. coli BC with Leu-2 re-
placed with Val, which was con¢rmed by amino acid sequencing.
2.3. Site-directed mutagenesis of Lys-238 of BC
Lys-238 was in the S2 (SmaI/KpnI) segment of pTBC. Hence, mu-
tated forms of S2 need to be prepared to construct Lys-238 mutants.
This was carried out by the polymerase chain reaction with the oli-
gonucleotides listed in Fig. 1 as primers. Primer A1 corresponds to
nucleotides 337^369 in the coding sequence of BC. Primer A2 was
designed to cover nucleotides 715^747. Primer A3 was designed to
cover nucleotides 847^871 in the complementary sequence. Primers
A4(Ala), A4(Gln) and A4(Arg) were designed to convert Lys-238 to
Ala, Gln and Arg, respectively and were to cover nucleotides 688^720
in the complementary sequence. The PCR reaction was performed
with 0.2 WM each of primers A1 and A4(Ala), A4(Gln) or A4(Arg)
and 0.5 ng of pTBC under the conditions described above to give S2-
1. Likewise, S3-1 was prepared with primers A2 and A3 and 0.5 ng of
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pTBC. The PCR products were electrophoresed in agarose gel and
recovered with a Geneclean II DNA puri¢cation kit. A second round
of PCR was then performed analogously with 0.5 ng each of the PCR
products S2-1 and S3-1 as primers and template with a program
consisting of 94‡C for 3 min, 40‡C for 2 min and 60‡C for 3 min in
the ¢rst cycle and 94‡C for 1 min, 40‡C for 2 min and 62‡C for 3 min
in 2^35 cycles. This PCR produced a V1000-bp DNA fragment.
SmaI (nucleotides 792^797) and KpnI (nucleotides 817^822) digestion
yielded a 426-bp DNA fragment (S2m). It was puri¢ed by agarose gel
electrophoresis, ligated into pBluescript II SK+ and DNA sequence
was determined. Thus, mutants replacing Lys-238 with Ala, Gln or
Arg, denoted as K238A, K238Q and K238R, respectively, were ob-
tained.
2.4. Determinatin of enzyme activity and protein concentration
Over-expressed BC was puri¢ed in a way analogous to that for
native BC [2] with some modi¢cations. Enzyme activity was measured
by the spectrophotometric method of Tipton and Cleland [8] using
free biotin as a carboxyl acceptor. Protein concentration was deter-
mined either by the micro-Biuret method [9] or by the Bradford
method [10]. The Km values of the recombinant enzyme were deter-
mined from double-reciprocal plots of the BC activity against sub-
strate concentration.
3. Results
3.1. Properties of over-expressed BC
To obtain mutants of biotin carboxylase (BC), an over-ex-
pression system was established based on a plasmid (pTBC)
which is capable of expressing E. coli BC with Leu-2 replaced
with Val. E. coli JM109 cells carrying pTBC over-expressed a
protein with an apparent molecular weight of 51 000 in the
presence of IPTG. This value is consistent with the protomer
molecular weight of E. coli BC [1,2]. BC was over-produced
about 2000-fold over endogenous under the present condi-
tions. The over-expressed BC was puri¢ed to higher than
95% homogeneity as assessed by sodium dodecylsulfate-poly-
acrylamide gel electrophoresis (Fig. 2). About 30 mg of BC
were obtained from 2 l of cell culture. The speci¢c activity of
the puri¢ed BC, 1.1 units/mg, was comparable to that of the
native [8]. The Km values for the three substrates, biotin, bi-
carbonate and ATP (Table 1), were also comparable to those
given in the literature [11]. This preparation was used in the
following modi¢cation experiments.
The mutant enzymes K238A, K238Q and K238R were iso-
lated in yields of 5, 5 and 30 mg from a 2-l cell culture,
respectively. The lower yields of K238A and K238Q were
due to their vulnerability to proteolysis : they underwent lim-
ited proteolysis to give a smaller molecular weight protein
(35 or 27 kDa) during puri¢cation. Once isolated in pure
form, they were as stable as the wild type.
3.2. A⁄nity labeling of BC
BC (50 WM) was allowed to react with 100 WM AP2-PL at
4‡C for various periods of time. Following reduction with
1 mM sodium borohydride, the residual enzyme activity was
determined. As shown in Fig. 3, the enzyme activity decreased
with the time of incubation with the reagent. Unlike AP2-PL,
PLP was hardly capable of inactivating BC under the same
reaction conditions. ATP, ADP, inorganic phosphate and bi-
carbonate protected BC from inactivation by AP2-PL to vary-
ing degrees, ATP giving the greatest protection (Fig. 4).
To determine the stoichiometry of inactivation by AP2-PL,
correlation of the residual enzyme activity with the £uores-
cence intensity of the sample was studied. BC was modi¢ed by
AP2-PL in a similar manner. The inactivation mixtures were
applied to a gel ¢ltration column [12]. The £uorescence of the
pyridoxyl lysine moiety, protein concentration, enzyme activ-
ity of £ow-through fractions were measured. As shown in Fig.
5, the £uorescence intensity increased linearly with a decrease
in enzyme activity. Extrapolation of the line to zero enzyme
activity gave a stoichiometry of 1.02 mol of reagent bound per
mol of enzyme.
Following dialysis, the inactivated enzyme (12.5 mg) was
digested with lysyl endopeptidase (w/w, 1:15) at 37‡C for
24 h. The resulting peptide mixture was separated by high
performance liquid chromatography on a C4 column. As
shown in Fig. 6, a virtually single £uorescent peptide was
observed, which accounted for at least 70% of the total £uo-
rescence. This peptide was rechromatographed on a C18 col-
umn to give a nearly homogeneous peptide. The amino acid
sequence of this peptide was determined to be Gln-Arg-Arg-
His-Gln-Xaa. At the sixth cycle of Edman degradation an
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Fig. 1. Oligonucleotides used for site-directed mutagenesis of Lys-
238 of E. coli BC. The underlines represent the mutated site.
Fig. 2. SDS electrophoresis of 0.8 Wg each of wild-type and mutated
forms of BC on a 12.5% polyacrylamide gel. Lane 1: wild-type;
lane 2: K238A; lane 3: K238Q; lane 4: K238R. The arrowhead in-
dicates the band of BC.
Table 1
Kinetic parameters for wild-type and mutant BCs
Enzyme Vmax (units/mg) Km (mM)
ATP Bicarbonate Biotin
Wild-type 1.67 0.17 1.8 160
K238A 0.66 21 3.7 180
K238Q 0.44 8.6 3.9 140
K238R 0.32 13 6.8 180
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unknown amino acid (Xaa) was released and after that iden-
ti¢cation of any amino acid was no more possible. This se-
quence up to the ¢fth is completely consistent with amino acid
numbers 233^237 of E. coli BC. Since the amino acid at 238 is
Lys, the data suggest strongly that it was Lys-238 which was
modi¢ed by AP2-PL. Of the 30 lysine residues of E. coli BC
virtually a single lysine was modi¢ed with high speci¢city.
3.3. Properties of Lys-238 mutants of BC
To assess the role of Lys-238, this residue was converted to
Ala, Arg or Gln by site-directed mutagenesis. Kinetic studies
on the biotin-dependent ATP degradation of these mutants
K238A, K238R and K238Q were carried out. All the mutants
showed more or less activity; K238A was the most active and
rather surprisingly K238R was the least active (Table 1). Their
Km values for ATP were 50^120 times higher than that of
wild-type, while the Km values of the mutants for bicarbonate
increased 2^4 times that of the wild type. The Km value for
biotin was not a¡ected much by the substitution. These data
indicate that the binding of ATP was impaired most by the
substitution of Lys-238.
4. Discussion
As shown above, Lys-238 of E. coli BC was speci¢cally
modi¢ed by AP2-PL and mutation of this residue resulted in
a marked decrease in its ATP binding ability, strongly sug-
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Fig. 3. Time course of inactivation of BC by AP2-PL or PLP. A in-
activation mixture (100 Wl) containing 50 WM BC, 25 mM HEPES
(pH 8.0), 5 mM MgCl2, 20% glycerol and 100 WM AP2-PL (b) or
PLP (a) was incubated at 4‡C. At the indicated time, the mixture
was reduced with 1 mM sodium borohydride. The residual activity
was measured.
Fig. 4. E¡ect of substrates on the inactivation of BC by AP2-PL.
The inactivation mixture (100 Wl) containing 50 WM BC, 25 mM
HEPES (pH 8.0), 5 mM MgCl2, 20% glycerol and 100 WM AP2-PL
(b) plus 1 mM ATP (a), 5 mM bicarbonate (R), 5 mM ADP (O),
or 5 mM inorganic phosphate (F) was incubated at 4‡C. At the in-
dicated time, the mixture was reduced with 1 mM sodium borohy-
dride and the residual activity was measured.
Fig. 5. Relationship between inactivation of BC by AP2-PL and the
amount of label incorporated into the monomer of the dimeric en-
zyme. The enzyme concentration was determined by the micro-Buret
method [8].
Fig. 6. High-performance liquid chromatography of the AP2-PL-la-
beled peptide of BC. The labeled enzyme was digested with lysyl en-
dopeptidase and applied to a C4 column. The peptides were eluted
by linear gradient of 0.1% tri£uoroacetic acid to 0.095% tri£uoro-
acetic acid containing 60% acetonitrile over 40 min at £ow rate
1 ml/min. Absorbance at 215 nm (upper panel) and £uorescence at
390 nm excited at 325 nm (lower panel) were monitored.
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gesting that Lys-238 participates in the binding of ATP. This
¢nding is consistent with the X-ray di¡raction data on BC,
which revealed that Lys-238 is located in the putative active
site cavity [4]. Also present in this cavity is a universally con-
served sequence, Glu-X-Asn-X-Arg, in amino acid numbers
288^292. Site-directed mutagenesis of these three residues,
Glu, Asn and Arg, resulted in total loss of enzymic activity
in some cases (unpublished observation in this laboratory),
suggesting that they participate directly in the catalysis of
this enzyme. Lys-238 is in close proximity to these residues
and if the Q-phosphate of ATP is in contact with this residue,
the phosphate could be readily transferred by the action of the
catalytic machinery of the enzyme. Furthermore, Lys-238 is
conserved in all of the biotin-depending enzymes which have
been sequenced to date, suggesting a common role in all of
them.
Biotin-dependent carboxylases including E. coli BC share a
Gly-rich sequence in the form of Gly-Gly-Gly-Gly-Arg-Gly or
Gly-Gly-Gly-Gly-Lys-Gly [13], which have been supposed to
be their ATP-binding site [3,14]. This notion was based on a
sequence analogy to the well-established nucleotide-binding
sequence Gly-X-X-X-X-Gly-Lys [15,16], where the Lys under-
goes electrostatic interaction with ATP. The Gly-rich se-
quence of BC is located in the B domain, far away from the
putative active site composed of such residues as Glu-288 and
Arg-292 (see above). When ATP is anchored at Lys-238 elec-
trostatically no part of the nucleotide seems to interact with
the Gly-rich region, unless the protein undergoes a drastic
conformational change. Some conformational change seems
to be probable, since the Gly-rich region of the B domain
was reported to be £exible [4], but a change as large as to
enable the Gly-rich sequence to come into contact with the
cavity-bound ATP is highly unlikely. Hence, we have to con-
clude that the Gly-rich sequence of BC and presumably of
related enzymes does not participate in ATP binding.
Recently, it was found that the three-dimensional structure
of BC is similar to those of some ADP-forming ligases [17,18].
Carbamoyl-phosphate synthetase (CPS) is such an example,
shares conserved primary sequences with BC and is believed
to have evolved from a common ancestor [13]. The B domain
of CPS, carrying the conserved Gly-rich sequence, was as-
sumed to undergo a conformational change upon nucleotide
binding [18]. Furthermore, mutation of the Gly-rich sequence
of CPS resulted in a signi¢cant decrease in its activity [19].
The Gly-rich sequence of glutathione synthetase, another
ADP-forming ligase, is supposed to serve as a lid for the
active site cavity, thereby holding enzyme-bound substrates
in correct orientation or shielding the active site from water
[20]. By reference to these observations, it may be reasonable
to assume that the Gly-rich region of BC plays a similar
important role in the functioning of BC. A role as a lid for
the active site is an attractive possibility, since the B domain
of BC is located near the entrance to the cavity, though its
orientation relative to the main body is di¡erent from that of
the other ADP-forming ligases [17,18]. This hypothesis and
other possibilities including a conformational change of the
B domain await experimental veri¢cation.
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